ELAHERE (mirvetuximab soravtansine-gynx) – folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer therapy in India
ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
| Brand Name: | ELAHERE |
| Generic Name: | mirvetuximab soravtansine-gynx |
| Strength: | • Injection: 100 mg/20 mL (5 mg/mL) in a single-dose vial. |
| Manufacturer: | ImmunoGen |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
ELAHERE must always be used under the supervision of a Registered Medical Practitioner (RMP).
Access ELAHERE for ovarian cancer, fallopian tube cancer, or primary peritoneal cancer treatment on a Named Patient Import Basis
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ELAHERE (mirvetuximab soravtansine-gynx) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
ELAHERE is a prescription medicine used to treat adults with folate receptor-alpha (FRɑ) positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Mirvetuximab soravtansine is indicated for the treatment of adults with folate receptor alpha (FRα) positive, platinum-resistant epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens. Recipients are selected for therapy based on an FDA-approved test.
ELAHERE (mirvetuximab soravtansine-gynx) injection, for intravenous use Initial U.S. Approval: 2022
Contact IPN – ELAHERE Access in India
For inquiries regarding availability, import process, or cost of ELAHERE (mirvetuximab soravtansine-gynx) :
India Pharma Network (IPN) : Headquartered in New Delhi, with branch offices in Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur and Lucknow, IPN supports medicine imports across India on a Named Patient Import Basis and for personal use only. Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774. Email: info@indianpharmanetwork.co.in
NEWS / UPDATES
- FDA approves mirvetuximab soravtansine-gynx for FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
- U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
- Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers
Compliance & Disclaimer
India Pharma Network acts solely as a facilitator for ELAHERE (mirvetuximab soravtansine-gynx) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:
- Strictly on a Named Patient Import Basis
- Exclusively for personal use
- Not for resale, distribution, or commercial sale
- Subject to applicable Indian laws and regulatory approvals
The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.
How to buy?
How to buy prescriptions drugs?
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
Contact Details
Indian Pharma Network
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
info@indianpharmanetwork.co.in
Steps to get access
If you possess a prescription issued by a Registered Medical Practitioner (RMP), IPN in Delhi can aid you in acquiring authentic medication globally. Our experts will furnish you with a detailed, step-by-step guidance on the lawful and secure process of importing prescription medicines based on the particulars you provide.
Step 1. Send a request for your medicine online:-
Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
Step 2. Verification of documents:-
We verify your a prescription and necessary documents to import drugs in small quantities for personal use.
Step 3. Permission to Import:-
After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.
Step 4. We source your medicine:-
Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.
Step 5. Delivery of medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.
Documentation Required
Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.
Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.
Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.
About IPN, Delhi
Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines can be imported for personal use under “patient name basis”. Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Registration Number : 07AAFFI2544E1ZO under GST Act. Specialized in Oncology Pharmacy. Helped more than 13500 patients. Helps you access to a FDA approved medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery.
FAQs
What is the generic name and the trade name of the drug?
Generic Name: mirvetuximab soravtansine-gynx. Trade Name: ELAHERE
Who market this drug?
ELAHERE is marketed by ImmunoGen.
Is the drug approved by the FDA?
Yes, ELAHERE is a prescription medicine approved by the FDA. Marketing Approval Date: 2024.
Is ELAHERE (mirvetuximab soravtansine-gynx) available in India?
Yes, ELAHERE is available in India on request. To get the access of ELAHERE in India, kindly contact Indian Pharma Network at M: 9811747774, 9891296838.
How much does ELAHERE cost in India?
The cost of mirvetuximab soravtansine-gynx India can vary. To procure this medication legally, you can call at 9811747774, 9891296838 or WhatsApp at 9811747774, 9891296838or email us at info@indianpharmanetwork.co.in
Is it safe to buy ELAHERE online in India?
Yes, to buy mirvetuximab soravtansine-gynx in India, request to send request at Indian Pharma Network (IPN). IPN, delhi will facilitate the supply of ELAHERE through legal channels.
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in






